OCRX

Ocera Therapeutics, Inc.
OCRX

Overview Fund Activity
Delisted

OCRX was delisted on the 8th of December, 2017.

Back to rankings

36 hedge funds and large institutions have $45.1M invested in Ocera Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
+18
Holders Change %
+100%
% of All Funds
1.04%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
19
Increased
9
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$4.25M
2
GTC
2
Ghost Tree Capital
New York
$2.48M
3
SFM
3
Sphera Funds Management
Israel
$1.28M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$821K
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$612K

Top Sellers

1
GPP
1
Great Point Partners
Connecticut
$3.29M
2
RCM
2
RA Capital Management
Massachusetts
$5.57M
3
Deutsche Bank
3
Deutsche Bank
Germany
$10K
4
QF
4
QVT Financial
New York
$7.18M
5
Morgan Stanley
5
Morgan Stanley
New York
$12K
Name Holding Trade Value Shares
Change 		Shares
Change %
Citadel Advisors
26
Citadel Advisors
Florida
$150K +$150K +14,205 New
GT
27
Glenmede Trust
Pennsylvania
$119K +$119K +11,352 New
CAM
28
ClariVest Asset Management
California
$67K +$67K +6,328 New
Bank of America
29
Bank of America
North Carolina
$53K +$52.6K +4,960 +12,400%
Wells Fargo
30
Wells Fargo
California
$47K +$47K +4,429 New
Morgan Stanley
31
Morgan Stanley
New York
$12K -$111K -10,727 -90%
TRCT
32
Tower Research Capital (TRC)
New York
$12K +$5.61K +533 +88%
AIG
33
American International Group
New York
$10.6K +$10.6K +1,000 New
Deutsche Bank
34
Deutsche Bank
Germany
$10K -$289K -28,887 -97%
LTFS
35
Ladenburg Thalmann Financial Services
Florida
$2K +$2K +150 New
Barclays
36
Barclays
United Kingdom
– -$1K -84 Closed
1
2